The study is aimed at developing innovative cyclodextrin based drug delivery systems for active tumour targeting. The new carriers have been designed in order to enhance the physicochemical properties of sparingly soluble and low stable drugs and allow for their site-specific release.
Modified Beta-cyclodextrins for site directed tumor therapy: in vitro characterization.
SALMASO, STEFANO;BERSANI, SARA;CALICETI, PAOLO
2006
Abstract
The study is aimed at developing innovative cyclodextrin based drug delivery systems for active tumour targeting. The new carriers have been designed in order to enhance the physicochemical properties of sparingly soluble and low stable drugs and allow for their site-specific release.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
